Xeomin Injection, Powder, Lyophilized, For Solution
Product Images NDC 46783-161
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Xeomin (NDC 46783-161). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Merz North America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Xeomin 02)
Figure 3 (Xeomin 03)
Figure 4 (Xeomin 04)
This appears to be a list of muscles and tendons in the forearm and hand, including the biceps brachii, pronator quadratus, flexor muscles (carpi ulnaris, pollicis, digitorum superficialis, and pollicis longus), opponens pollicis, adductor pollicis, and distal tendons of the flexor digitorum profundus. The note at the end suggests that some muscle bellies are not visible.*
Figure 5 (Xeomin 05)
Figure 6 (Xeomin 06)
This text appears to be describing different parts of the orbicularis oculi muscle, including the laceral and medial superior pre-tarsal part, the laceral canthus, and the inferolaceral portion. It also mentions the corrugator muscle. It is likely information pertaining to anatomy or medical study.*
Principal Display Panel (50 units/vial Label)
Principal Display Panel (- 50 units/vial Carton)
Principal Display Panel (100 units/vial Label)
The text provides a table that shows the "Cumulative Percentage of Patients" and "Change from Baseline on the TWSTRS" for three treatment groups. The treatment groups are not specified with clear headings, but it seems that they are XEOMIN (120 U), XEOMIN (240 U), and Placebo. The numbers in the table refer to the change in TWSTRS for each group, and the cumulative percentage of patients who fall into each category. It is not clear what TWSTRS stands for or what the numbers mean.*
Principal Display Panel (100 units/vial Carton)
Principal Display Panel (100 units/vial Label)
Principal Display Panel (100 units/vial Carton)
Principal Display Panel (50 units/vial Label)
This is a product description of a medication called "incobotulinumtoxinA" used for intramuscular injection. The medication is manufactured in Germany by Mz Pharmaceuticals GmbH and distributed in the USA by Marz North America, Inc. The medication comes in a single-dose vial, containing 50 units of the drug. The packaging includes warnings that dosing units of botulinum toxins are not interchangeable between commercial products and that the medication should be kept out of the reach and sight of children. The unused portion should be discarded, and the medication must be reconstituted with preservative-free 0.9% Sodium Chloride Injection, USP. The reconstituted medication should be stored in a refrigerator at 2 to 8 degrees Celsius for up to 24 hours.*
Principal Display Panel (50 units/vial Carton)
This is a description for a physician sample of a drug called incobotulinumtoxinA provided in a single-dose vial for intramuscular use. The vial has a dosage of 100 units and contains human albumin and naert. The enclosed medication guide should be dispensed to each patient for use. The product is manufactured by MERZ AESTHETICSĀ®. A warning is given that dosing units of botulinum toxins are not interchangeable between commercial products.*
Xeomin 15
This is a description of a medication called incobotulinumtoxinA. This medication comes in a 50-unit vial and is intended for intramuscular use only. It is essential to discard any unused portions as usual dosage depends on patient's health and medical condition. There is a medication guide enclosed in the package to be dispensed to each patient. The product contains Clostridium Botulinum Neurotoxin Type A along with human albumin and sucrose. The medication is manufactured in Germany, and it is distributed in the United States by Merz North America. The product should be kept in a refrigerator within the temperature range of 2 to 8 degrees Celsius. The author emphasizes that the dosing units of botulinum toxin are not interchangeable between commercial products, so it's essential to follow the prescribing physician's recommendations.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.